Zealand Pharma Competitors and Similar CompaniesClear all
Zealand Pharma's competitors and similar companies include Antag Therapeutics, Syntese, Biosyntia and Saniona.
 Zealand Pharma Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines. |  Antag Therapeutics Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases. |  Syntese Syntese is a company manufacturing Mesalazine, an active pharmaceutical ingredient (API) used in treating inflammatory bowel diseases. |  Biosyntia Biosyntia is a biotech company that specializes in synthetic biology and metabolic engineering. |  Saniona Saniona, a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. | |
Founding Date | Founding Date 1998 | Founding Date 2017 | Founding Date 1989 | Founding Date 2012 | Founding Date 2011 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Søborg, DK HQ Boston, US Marlborough, US | Locations København, DK HQ | Locations Hvidovre, DK HQ | Locations København, DK HQ | Locations Ballerup, DK HQ Glostrup, DK Waltham, US |
Employees | Employees 385 | Employees 20 | Employees 1322% increase | Employees 22 | Employees 22 |
Valuation ($) | Valuation ($) 8.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 42.9 m |
Financial | |||||
Revenue (est.) | Revenue (est.) kr9.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr434.4m (FY, 2025) |
Cost of goods | Cost of goods kr816k (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods kr5.4m (FY, 2025) |
Gross profit | Gross profit kr9.3b (FY, 2025) | Gross profit (kr13.1m) (FY, 2021) | Gross profit N/A | Gross profit N/A | Gross profit kr429m (FY, 2025) |
Net income | Net income kr6.5b (FY, 2025) | Net income (kr14.9m) (FY, 2021) | Net income N/A | Net income N/A | Net income kr284.7m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Antag Therapeutics
HQ
København, DK
Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases.
View companySyntese
HQ
Hvidovre, DK
Syntese is a company manufacturing Mesalazine, an active pharmaceutical ingredient (API) used in treating inflammatory bowel diseases.
View companyBiosyntia
HQ
København, DK
Employees
22
Biosyntia is a biotech company that specializes in synthetic biology and metabolic engineering.
View companySaniona
HQ
Ballerup, DK
Employees
22
Saniona, a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain.
View company